This company has been marked as potentially delisted and may not be actively trading. NASDAQ:DARA (DARA) (DARA) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (DARA) Stock (NASDAQ:DARA) 30 days 90 days 365 days Advanced Chart Get (DARA) alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.32▼$0.3352-Week Range N/AVolume13,850 shsAverage Volume118,843 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewDARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company's primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.Read More… Receive DARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (DARA) and its competitors with MarketBeat's FREE daily newsletter. Email Address DARA Stock News HeadlinesTop National Security Exec Kyle Draisey Joins Sagent as Chief Information Security Officer and Head of CybersecurityMay 30 at 5:23 AM | tmcnet.comDara Huang issues message to 'single mums' amid her blended family with Edoardo and BeatriceMay 28 at 2:59 PM | msn.comSocial Security Could Change Forever — Here's What I KnowWhen we say the way income could be calculated for Social Security is about to change forever — we don't make that claim lightly. These institutions pay us top dollar because we track exactly how big federal changes like this could send ripples through the stock market. And right now, we are sounding the alarm.May 30, 2025 | Altimetry (Ad)Viral Again: Mukul Dev's One Of The Last Videos With Vindu Dara SinghMay 27 at 5:01 AM | msn.comDSpace: The Ukrainian theatre company bringing community to the foreMay 26, 2025 | msn.comUber CEO Dara Khosrowshahi's son still hasn't gotten his license and uses ride-hailing instead. He's not aloneMay 26, 2025 | msn.comVindu Dara Singh remembers Mukul Dev: ‘He was never the same after his mother’s death’May 25, 2025 | msn.com'Son of Sardaar' actor Mukul Dev's last rites held in Delhi, Vindu Dara Singh pays tributesMay 25, 2025 | msn.comSee More Headlines DARA Stock Analysis - Frequently Asked Questions How were (DARA)'s earnings last quarter? (DARA) (NASDAQ:DARA) issued its quarterly earnings results on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.14). The specialty pharmaceutical company had revenue of $1.18 million for the quarter, compared to analyst estimates of $0.83 million. What other stocks do shareholders of (DARA) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (DARA) investors own include Castleton Technology (CTP), Richland Resources Ltd (RLD.L) (RLD), Thor Energy (THR), Global Invacom Group (GINV), Legendary Investments (LEG), iPass (IPAS) and Aeterna Zentaris (AEZS). Company Calendar Last Earnings11/02/2015Today5/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:DARA CIK919745 Webwww.darabiosciences.com Phone+1-816-9147027FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:DARA) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuffett’s Next Move Could Shock Wall StreetIn just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (DARA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (DARA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.